NCT05517564
First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 1, 2022
Completion: Jun 30, 2023